HOME >> BIOLOGY >> NEWS
Monitoring epithelial plasticity, one cell at a time

The kidneys maintain plasma volume and composition by adapting to shifts in the concentration of ions and other solutes. Some years ago, Schwartz and colleagues identified one such homeostatic mechanism, in which acidosis alters the cellular population within the cortical collecting duct (CCD) of the kidney. Over a period of days, acidosis induces one epithelial cell type in the CCD, the so called b-intercalated cells, to adopt the characteristics of another cell type, the a-intercalated cells. Intercalated cells of both types employ a proton ATPase and an anion antiporter system to transport H+ and HCO3? ions across the epithelium. However, because they differ in the distribution of these proteins on their apical and basolateral surfaces, these two cell types affect plasma pH in opposing directions: b cells secrete HCO3? toward the lumen, acidifying the plasma, whereas a cells reabsorb HCO3?, helping to neutralize plasma pH. Now, Schwartz et al. have revisited the b-to-a shift, this time using CCDs cultured ex vivo, a system that allowed them to observe the fates of individual cells over several hours following reduction of external pH. Just as is seen in the living kidney following a period of acidosis, CCD cells undergo a morphological change and shift their polarity to favor HCO3? reabsorption. Building on their earlier identification of the ECM protein hensin as a key factor in epithelial differentiation, the authors examined the effect of a hensin blocking antibody in their ex vivo system. They confirm that this antibody specifically inhibits the conversion to the a cell phenotype. Hensin is ubiquitously expressed, generally in a soluble form that has no effect on the intercalated cell polarity. Interestingly, however, the hensin binding protein galectin-3 is expressed by a but not b cells and appears to favor the formation of insoluble, ECM-bound hensin that is biologically active. With the ability to monitor individual cells in real time, it should be possib
'"/>

Contact: John Ashkenas
scied@the-jci.org
416-946-7593
Journal of Clinical Investigation
2-Jan-2002


Page: 1 2

Related biology news :

1. Monitoring macrophages detects dementia
2. Monitoring malaria: Genomic activity of the parasite in human blood cells
3. New Monitoring Technique Checks Thyroid Cancer Without Misery
4. New Environmental Monitoring System To Reduce Costs And Improve Efficiency
5. Intraepithelial neoplasia may be a leading risk factor for prostate and ovarian cancers
6. Researchers develop first mouse model of epithelial ovarian cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... , ... August 19, 2020 , ... ... LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty ... recently published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research ...
(Date:8/21/2020)... ... August 20, 2020 , ... ... Hassan Movahhed , a Clinical Operations executive with expertise in clinical trial planning ... the firm as an Expert Consultant. Throughout his career, Mr. Movahhed has helped ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced ... for public health agencies of all sizes. With a focus on tracking symptoms ... find appropriate health care, Mosio helps public health departments automate communications and provide ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed ... prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique ... independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its platform ... Biologics since its formation in 2016, the company is relaunching itself under the Ardent ... its base of innovative therapies for osteoarthritis and cancer. , ...
Breaking Biology Technology:
Cached News: